SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-046714
Filing Date
2022-08-18
Accepted
2022-08-18 17:39:09
Documents
2
Period of Report
2022-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4151
2 EX-24 DOCUMENT attachment1.htm EX-24 4038
  Complete submission text file 0001209191-22-046714.txt   9492
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Smith Brendan (Reporting) CIK: 0001857492 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 221178278